Selectins are adhesion receptors expressed by leucocytes, platelets, and endothelial cells. They mediate the initial binding of leucocytes to vascular endothelium in the post-capillary venules. This is an essential first step in leucocyte migration into tissue. The selectin family of adhesion receptors consists of three C-type lectins (E, P, and L selectin ligands. E-selectin binds E-selectin ligand 1 (ESL-1) in mouse neutrophils, which is a chicken fibroblast receptor and not related to other adhesion receptor families. E-selectin also binds P-selectin glycoprotein 1 (PSGL-1) but with lower affinity than P-selectin.
ligands. E-selectin binds E-selectin ligand 1 (ESL-1) in mouse neutrophils, which is a chicken fibroblast receptor and not related to other adhesion receptor families. E-selectin also binds P-selectin glycoprotein 1 (PSGL-1) but with lower affinity than P-selectin. (sLeX). The EGF domain may also play a part in ligand recognition. The multiple SCR domains (two for L-selectin, six for E-selectin, and nine for P-selectin) probably act as spacer elements, ensuring optimum positioning of the lectin and EGF domains for ligand interaction. For high affinity binding the carbohydrate structures recognised by selectins need to be presented on a peptide backbone. This introduces a level of specificity. Most of the selectin glycoprotein counter receptors contain heavily 0-glycosylated mucin-like domains. The potential mucin-like ligands for L-selectin have been defined as GlyCAM-1, CD34, and mouse (but probably not human) MAdCAM-1. These receptors have been shown to play a part in lymphocyte recirculation (homing) but their importance in inflammation is uncertain. GlyCAM-1 lacks a transmembrane domain and it is uncertain whether it can act as a endothelial ligand for L-selectin. Functional studies have suggested that there is an inducible L-selectin counter receptor on endothelium but this remains to be defined, although in vitro human E-selectin has been shown to bind L-selectin.
P-selectin glycoprotein 1 (PSGL-1) is a counter receptor for P-selectin expressed by all leucocytes.3 It has a mucin-like domain although N-terminal sulphated tyrosine residues are also important in binding. PSGL-1 binds E-selectin, but with lower affinity, and also possibly L-selectin where it may in part mediate neutrophil aggregation. The function of PSGL-1 appears to be controlled by differential glycosylation depending on the cell type or activation status of the cell on which it is expressed. An E-selectin ligand on mouse neutrophils has been identified as E-selectin ligand 1 (ESL-1). This was an isoform of a fibroblast growth factor and not a mucin. FUNCTION mediators, such as thrombin or histamine, stored P-selectin is mobilised to the cell surface. In vitro studies in cultured human umbilical vein endothelial cells have shown this expression to be downregulated within minutes as a result of internalisation and degradation.6 Interleukin 3 can result in expression for up to four days. In vivo experiments studying leucocyte rolling in mouse cremaster muscle venules by intravital microscopy have indicated that Pselectin mediates the early rolling in response to the surgery (0-60 minutes), while at 60-120 minutes rolling is dependent on L-selectin. Constitutive expression of P-selectin has been observed on vessels in rheumatoid synovium and on nasal polyp endothelium, suggesting a role in chronic inflammation.7 E-selectin is expressed by endothelial cells as a result of de novo protein synthesis in response to cytokine stimulation. It acts as a skin homing receptor for a subset of T cells that express the cutaneous lymphocyte antigen (CLA) which contains an sLeX-like structure and is a ligand for E-selectin. CLA-positive T cells were greatly enriched in the skin ofpatients with atopic dermatitis but were largely absent from T cells in the bronchoalveolar lavage fluid of asthmatic subjects.8 E-selectin can also mediate granulocyte binding to HUVEC. It is expressed in the airways ofpatients with asthma and rhinitis although no consistent difference from controls has been reported. Expression is induced after allergen challenge in both the airways and skin.9 Raised concentrations of soluble E-selectin have been detected in subjects with acute severe asthma but the levels did not correlate with disease activity.
ANTIBODY STUDIES AND SELECTIN "KNOCK-OUT" MICE
A number of studies have attempted to define the role of selectins in various inflammatory models by the use of either monoclonal antibodies or "knock-out" mice in which the germline gene for the selectin has been disabled. The effects on lung inflammation vary depending on the exact details of the model and there is no simple message. In lung damage associated with intravenous cobra venom factor or a distant ischaemia-reperfusion injury in which damage appears to be indirect and not associated with neutrophil migration into the lung, monoclonal antibodies against each of the selectins protected against increased permeability and lung haemorrhage by about 50% as they did in IgG immune complex mediated inflammation which is neutrophil dependent.
In contrast, in a P-selectin "knock-out" mouse no difference in neutrophil migration into the lung during Streptococcus pneumoniae induced pneumonia was observed compared with wild type mouse, whereas neutrophil migration in S pneumoniae induced peritonitis was inhibited by about 70%. An anti-E-selectin monoclonal antibody was also able to block neutrophil migration into the lung in a primate model of asthma and attenuate the late response.'0 An E-selectin "knock-out" mouse was healthy with little discernible abnormality in immune func-tion unless antibodies against P-selectin were also given. Consistent with this, a double mutant with deletion of both E-and P-selectin genes was severely immunocompromised although lung infection was not a significant feature." The P-and L-selectin "knock-out" mice both had impaired neutrophil rolling and migration into the peritoneum after instillation of thioglycollate but, as mentioned above, no obvious impairment of lung immunity was found. In the L-selectin "knock-out" mice there was also atrophy of the peripheral lymph nodes consistent with its role as a peripheral lymphocyte homing receptor. The "knock-out" mice confirm the overlap in function between the selectins, particularly between E-and Pselectin. More models involving pulmonary inflammation need to be tested before a full understanding of the importance of selectins in lung immunity can be defined. 
